The genetics of multiple sclerosis and its experimental models

Area of Science:

• Immunogenetics
• Neuroimmunology
• Genetics of Autoimmune Diseases

Background:

• Multiple sclerosis (MS) is a complex autoimmune disease with a significant genetic component.
• Understanding the genetic architecture of MS is crucial for developing effective treatments.

Purpose of the Study:

• To review current knowledge on the genetic aetiology of multiple sclerosis (MS).
• To examine the role of human leucocyte antigen (HLA) genes and non-HLA genes in MS.
• To explore the utility of experimental MS models in genetic research.

Main Methods:

• Review of existing literature on MS genetics.
• Analysis of genetic associations within the human leucocyte antigen (HLA) complex.
• Identification and characterization of non-HLA genes implicated in MS.
• Integration of findings from experimental autoimmune encephalomyelitis (EAE) models.

Main Results:

• Human leucocyte antigen (HLA) class II alleles exhibit a hierarchy of risk and protective effects in MS.
• HLA class I genes are also associated with MS susceptibility.
• Numerous non-HLA genes, each with small effect sizes (e.g., IL2RA, IL7RA with odds ratio ~1.3), are implicated in MS.
• Experimental models suggest a polygenic model for MS, with over 100 genes potentially involved.

Conclusions:

• Both HLA and non-HLA genes play significant roles in MS pathogenesis.
• The identification of multiple non-HLA genes opens avenues for future research.
• Further elucidation of these genetic factors may lead to more targeted therapies and gene-environment interaction studies for MS.